Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07402915
What this trial is testing

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal
AstraZeneca 24
Testing effectiveness (Phase 2)Study completedNCT01313078
What this trial is testing

Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPrimary Peritoneal Neoplasms
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT02022917
What this trial is testing

Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Chang Gung Memorial Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00017017
What this trial is testing

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00305838
What this trial is testing

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 200
Early research (Phase 1)Looking for participantsNCT07665515
What this trial is testing

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerHGSOCHGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd 50
Early research (Phase 1)Study completedNCT01339650
What this trial is testing

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian
AbbVie (prior sponsor, Abbott) 93
Testing effectiveness (Phase 2)Ended earlyNCT00888810
What this trial is testing

Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer

Who this might be right for
CancerOvarianRelapse+1 more
Centre Francois Baclesse 39
Testing effectiveness (Phase 2)Ended earlyNCT01312389
What this trial is testing

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Large-scale testing (Phase 3)Looking for participantsNCT06161025
What this trial is testing

Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Solid Cancer
Daiichi Sankyo 860
Not applicableLooking for participantsNCT06855706
What this trial is testing

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Who this might be right for
Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+10 more
Roswell Park Cancer Institute 120
Testing effectiveness (Phase 2)Study completedNCT03092518
What this trial is testing

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Who this might be right for
Gastric AdenocarcinomaEsophagogastric JunctionGastric Cancer
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00008138
What this trial is testing

S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 62
Early research (Phase 1)Ended earlyNCT00003378
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT00428610
What this trial is testing

Chemotherapy Treatment for Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Eli Lilly and Company 103
Not applicableStudy completedNCT02973750
What this trial is testing

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+3 more
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT05538624
What this trial is testing

Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Who this might be right for
Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more
Avenge Bio, Inc 14
Not applicableStudy completedNCT05649969
What this trial is testing

STRONG Program for Cancer Patients

Who this might be right for
Gastrointestinal Cancer
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)WithdrawnNCT05126342
What this trial is testing

Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CancerPrimary Peritoneal Cancer
AGO Research GmbH
Early research (Phase 1)Ended earlyNCT01202890
What this trial is testing

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Carcinoma+1 more
New Mexico Cancer Research Alliance 1
Next Page